Angitia Biopharmaceuticals
Clinical trials sponsored by Angitia Biopharmaceuticals, explained in plain language.
-
New drug aims to boost healing in back surgery
Disease control OngoingThis study is testing if a single dose of an experimental drug, AGA111, can help patients heal better after spinal fusion surgery for severe lower back pain. About 400 adults who have not gotten relief from other treatments will have the drug or a placebo applied during their sur…
Phase: PHASE3 • Sponsor: Angitia Biopharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug trial aims to strengthen bones in older women
Disease control OngoingThis study is testing whether an investigational drug called AGA2118 can improve bone mineral density in postmenopausal women with low bone mass. Over 12 months, researchers will compare different doses of AGA2118 against a placebo to see which is most effective and safe. The goa…
Phase: PHASE2 • Sponsor: Angitia Biopharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC